journal article·2023-03-10

Quasi-HKUST-1 Nanostructures with Enhanced Catalytic Activity and Water Stability for Bacteria-Infected Diabetic Wound Therapy

Linxi Chen, Chuyan Lin, Xianhua Shi, Luyong Zhang, Duanping Sun

ACS Applied Nano Materials· Volume 6· Issue 5
Publisher page

Abstract

Metal–organic frameworks (MOFs), a type of nanomaterial, are generating increasing interest in mimicking the structure and function of natural enzymes for sensors and therapeutics. Their catalytic and therapeutic efficiencies, however, are subpar due to their limited catalytic activity and structural stability. Quasi-MOFs (Q-MOFs) exhibit improved metal–carrier interactions and provide synergistic catalysis by exposing inorganic nodes to the object species while retaining a portion of the porous structure of MOFs. In this work, a quasi-Cu-based metal–organic framework was designed to improve bacteria-infected diabetic wound therapy. A series of quasi-HKUST-1 (QHKUST-1) that were created from the low-temperature calcination of HKUST-1 were used for the initial catalytic reaction. Then, the optimal QHKUST-1 has enhanced peroxidase activity to catalyze H 2 O 2 to generate hydroxyl groups for antibacterial therapy. Comparing the previously water-sensitive HKUST-1 to the enhanced moisture stability and catalytic capabilities of QHKUST-1. Furthermore, cell migration experiments demonstrate that QHKUST-1 can promote cell migration more effectively than HKUST-1. Finally, animal experiments indicated that QHKUST-1 can effectively facilitate bacteria-infected diabetic wound healing with good antibacterial activity and biocompatibility. This work highlights the potential of Q-MOF for antibacterial therapy and shows significant promise for the future management of bacterially infected wounds.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of New Drug Discovery and Evaluation, Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou 510006, Guangdong, China

Key Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou 510699, Guangdong, China

New Drug Screening Center, Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing 210009, China

Funding

Department of Education of Guangdong Province · National Natural Science Foundation of China · Natural Science Foundation of Guangdong Province · High-Level Clinical Key Specialty in Guangdong Province · National Key Clinical Specialty Construction Project

References (50)

Show source-provided references
1. 10.1038/4624810.1038/46248 ↗
2. 10.1126/science.106720810.1126/science.1067208 ↗
3. 10.1126/science.123044410.1126/science.1230444 ↗
4. 10.1021/cr300014x10.1021/cr300014x ↗
5. 10.1021/acs.chemrev.9b0075710.1021/acs.chemrev.9b00757 ↗
6. 10.1021/cr200324t10.1021/cr200324t ↗
7. 10.1039/C6CS00930A10.1039/C6CS00930A ↗
8. 10.1039/b807080f10.1039/b807080f ↗
9. 10.1016/j.snb.2020.12790910.1016/j.snb.2020.127909 ↗
10. 10.1021/acsami.0c1126910.1021/acsami.0c11269 ↗
11. 10.1039/C9SC03916C10.1039/C9SC03916C ↗
12. 10.1021/cr500258910.1021/cr5002589 ↗
13. 10.1039/C7CS00614D10.1039/C7CS00614D ↗
14. 10.1007/s11426-020-9781-710.1007/s11426-020-9781-7 ↗
15. 10.1021/acsami.1c1986210.1021/acsami.1c19862 ↗
16. 10.1016/j.ccr.2022.21464310.1016/j.ccr.2022.214643 ↗
17. 10.1016/j.chempr.2018.03.00910.1016/j.chempr.2018.03.009 ↗
18. 10.1021/acssuschemeng.0c0180010.1021/acssuschemeng.0c01800 ↗
19. 10.1021/acsami.1c1986210.1021/acsami.1c19862 ↗
20. 10.1002/adhm.20210071610.1002/adhm.202100716 ↗
21. 10.1186/s12951-020-00755-710.1186/s12951-020-00755-7 ↗
22. 10.1007/s40200-020-00660-810.1007/s40200-020-00660-8 ↗
23. 10.1002/dmrr.327310.1002/dmrr.3273 ↗
24. 10.1126/sciadv.aaw396310.1126/sciadv.aaw3963 ↗
25. 10.1097/00152192-200511000-0000710.1097/00152192-200511000-00007 ↗
26. 10.1039/D0BM01747G10.1039/D0BM01747G ↗
27. 10.1136/bmjopen-2019-03060810.1136/bmjopen-2019-030608 ↗
28. 10.1016/j.ejphar.2014.02.03310.1016/j.ejphar.2014.02.033 ↗
29. 10.1073/pnas.123199410010.1073/pnas.1231994100 ↗
30. 10.1016/j.biomaterials.2015.03.01810.1016/j.biomaterials.2015.03.018 ↗
31. 10.1002/adfm.20160487210.1002/adfm.201604872 ↗
32. 10.1016/j.cej.2019.12377510.1016/j.cej.2019.123775 ↗
33. 10.1016/j.jhazmat.2020.12442610.1016/j.jhazmat.2020.124426 ↗
34. 10.1002/smll.20220017810.1002/smll.202200178 ↗
35. 10.1126/science.283.5405.114810.1126/science.283.5405.1148 ↗
36. 10.1016/j.jallcom.2012.06.03010.1016/j.jallcom.2012.06.030 ↗
37. 10.3389/fchem.2021.74363710.3389/fchem.2021.743637 ↗
38. 10.3390/membranes1007014010.3390/membranes10070140 ↗
39. 10.1021/acsanm.1c0091010.1021/acsanm.1c00910 ↗
40. 10.1021/jacs.8b0640710.1021/jacs.8b06407 ↗
41. 10.1016/j.ccr.2021.21392910.1016/j.ccr.2021.213929 ↗
42. 10.1002/adfm.20180148410.1002/adfm.201801484 ↗
43. 10.1016/S0896-8446(03)00040-810.1016/S0896-8446(03)00040-8 ↗
44. 10.1021/acsami.8b0345710.1021/acsami.8b03457 ↗
45. 10.1021/acscatal.7b0048310.1021/acscatal.7b00483 ↗
46. 10.1021/acsami.9b2314710.1021/acsami.9b23147 ↗
47. 10.1021/jacs.8b0522310.1021/jacs.8b05223 ↗
48. 10.1021/acsami.1c1920910.1021/acsami.1c19209 ↗
49. 10.1161/01.CIR.0000069330.41022.9010.1161/01.CIR.0000069330.41022.90 ↗
50. 10.1002/smll.20200055310.1002/smll.202000553 ↗